SCHEMBL4885743

SCHEMBL4885743

COC(=O)c1cccc2c1nc(CN(C)C1CCCc3cccnc31)n2C

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 20/20 0.53
KCNH2 Q12809 1/20 0.46
ACE P12821 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4889441 0.91 CXCR4 (0.55) CXCR4KCNH2ACE
SCHEMBL4886610 0.86 CXCR4 (0.55) CXCR4KCNH2
SCHEMBL4889445 0.85 CXCR4 (0.51) CXCR4KCNH2ACE
SCHEMBL4891041 0.82 CXCR4 (0.45) CXCR4KCNH2
SCHEMBL4890982 0.80 CXCR4 (0.54) CXCR4KCNH2
SCHEMBL4889183 0.80 CXCR4 (0.61) CXCR4KCNH2
SCHEMBL29318376 0.79 CXCR4 (0.76) CXCR4KCNH2
SCHEMBL4881719 0.78 CXCR4 (0.57) CXCR4KCNH2ACE
SCHEMBL5240535 0.77 CXCR4 (0.54) CXCR4KCNH2
SCHEMBL4885119 0.74 CXCR4 (0.54) CXCR4KCNH2ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080045537-A1 Chemical Compounds SMITHKLINE BEECHAM CORPORATION 2008-02-21 US disclosed
US-20080045537-A1 Chemical Compounds SMITHKLINE BEECHAM CORPORATION 2008-02-21 US disclosed
US-20080045537-A1 Chemical Compounds SMITHKLINE BEECHAM CORPORATION 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045537-A1 Chemical Compounds CCR5, CXCR4, CXCR3 CXCR4 2/4885KCNH2 4733/4885ACE 3946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.